Acurx Announces Publication in ASM Confirming Data on its DNA pol IIIC Inhibitor Pipeline of Antibiotics Demonstrating a Potential Microbiome-Sparing Class Effect

Go back to Acurx Announces Publication in ASM Confirming Data on its DNA pol IIIC Inhibitor Pipeline of Antibiotics Demonstrating a Potential Microbiome-Sparing Class Effect
(NASDAQ: ACXP) Delayed: 1.15 --0 (-0%)
Previous Close $1.15    52 Week High $ 
Open $1.15    52 Week Low $ 
Day High $1.15    P/E N/A 
Day Low $1.15    EPS $ 
Volume 207